&lt;i&gt;Campylobacter&lt;/i&gt; Spp. Epidemiology and Antimicrobial Susceptibility in a Developing Country, Burkina Faso (West Africa)

Sangaré, Lassana; Nikiéma, AK; Zimmermann, Saskia; Sanou, Idrissa; Congo-Ouédraogo, Malika; Diabate, A.; Diandé, S; Guissou, PI

doi:10.4314/ajcem.v13i2.9

Cited by 13 publications

(18 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In Ethiopia, human campylobacteriosis was significantly associated with nonuse of latrines, water source, drinking unboiled water, bottle feeding, nutritional status, and exposure to domestic animals including cats, dogs, poultry, and pigeons [25]. In Burkina Faso, Campylobacter infections were most common among under-fives and those aged 21-40 years with more pet contacts [57].…”

Section: Campylobacter Infections In Humansmentioning

confidence: 99%

Prevalence, Risk Factors, and Antimicrobial Resistance Profiles of Thermophilic Campylobacter Species in Humans and Animals in Sub-Saharan Africa: A Systematic Review

Gahamanyi

Mboera

Matee

et al. 2020

International Journal of Microbiology

View full text Add to dashboard Cite

Thermophilic Campylobacter species are clinically important aetiologies of gastroenteritis in humans throughout the world. The colonization of different animal reservoirs by Campylobacter poses an important risk for humans through shedding of the pathogen in livestock waste and contamination of water sources, environment, and food. A review of published articles was conducted to obtain information on the prevalence and antimicrobial resistance (AMR) profiles of thermophilic Campylobacter species in humans and animals in sub-Saharan Africa (SSA). Electronic databases, namely, PubMed, Google Scholar, Research4life-HINARI Health, and Researchgate.net, were searched using the following search terms “thermophilic Campylobacter,” “Campylobacter jejuni,” “Campylobacter coli,” “diarrhea/diarrhoea,” “antimicrobial resistance,” “antibiotic resistance,” “humans,” “animals,” “Sub-Saharan Africa,” and “a specific country name.” Initially, a total of 614 articles were identified, and the lists of references were screened in which 22 more articles were identified. After screening, 33 articles on humans and 34 on animals and animal products were included in this review. In humans, Nigeria reported the highest prevalence (62.7%), followed by Malawi (21%) and South Africa (20.3%). For Campylobacter infections in under-five children, Kenya reported 16.4%, followed by Rwanda (15.5%) and Ethiopia (14.5%). The country-level mean prevalence in all ages and under-five children was 18.6% and 9.4%, respectively. The prevalence ranged from 1.7%–62.7% in humans and 1.2%–80% in animals. The most reported species were C. jejuni and C. coli. The AMR to commonly used antimicrobials ranged from 0–100% in both humans and animals. Poultry consumption and drinking surface water were the main risk factors for campylobacteriosis. The present review provides evidence of thermophilic Campylobacter occurrence in humans and animals and high levels of AMR in SSA, emphasizing the need for strengthening both national and regional multisectoral antimicrobial resistance standard surveillance protocols to curb both the campylobacteriosis burden and increase of antimicrobial resistance in the region.

show abstract

Section: Campylobacter Infections In Humansmentioning

confidence: 99%

Prevalence, Risk Factors, and Antimicrobial Resistance Profiles of Thermophilic Campylobacter Species in Humans and Animals in Sub-Saharan Africa: A Systematic Review

Gahamanyi

Mboera

Matee

et al. 2020

International Journal of Microbiology

View full text Add to dashboard Cite

show abstract

“…In Ouagadougou, the capital of Burkina Faso, Sangaré, Nikiéma, Zimmermann, Sanou, Congo-Ouédraogo, Diabaté, Diandé and Guissou [41] collected stool samples from 1246 enteritis patients from 2006 to 2008 and reported a Campylobacter isolation rate of 2.3%, with C. jejuni accounting for 51.8%, C. coli accounting for 13.8%, and C. upsaliensis accounting for 3.5%. In Kumasi, the capital of Ghana, Karikari, Obiri-Danso, Frimpong and Krogfelt [42] reported a Campylobacter prevalence of 17.3% in 202 patients who visited the Komfo Anokye Teaching Hospital from May to August 2013.…”

Section: Prevalence Of Campylobacter In Humansmentioning

confidence: 99%

“…In Burkina Faso, isolates from human stools showed 13.8% resistance to ciprofloxacin, 10.3% to tetracycline, and 10.3% to erythromycin [41]. A study in Abidjan, Ivory Coast Goualie, Essoh, Elise Solange, Natalie, Souleymane, Lamine Sebastien and Mireille [6], reported 79.5%, 38.5%, 17.9%, and 10.3% resistance of poultry C. jejuni isolates to nalidixic acid, ciprofloxacin, amoxicillin, and erythromycin, respectively.…”

Section: Antimicrobial Resistance (Amr) Patterns Of Campylobacter mentioning

confidence: 99%

Campylobacter at the Human–Food Interface: The African Perspective

et al. 2019

View full text Add to dashboard Cite

The foodborne pathogen Campylobacter is a major cause of human gastroenteritis, accounting for an estimated annual 96 million cases worldwide. Assessment of the true burden of Campylobacter in the African context is handicapped by the under-reporting of diarrhoeal incidents and ineffective monitoring and surveillance programmes of foodborne illnesses, as well as the minimal attention given to Campylobacter as a causative agent of diarrhoea. The present review of the literature highlights the variability in the reported occurrence of Campylobacter in humans and animal food sources across different countries and regions in Africa. Campylobacter infection is particularly prevalent in the paediatric population and has been isolated from farm animals, particularly poultry, and foods of animal origin. The reported prevalence of Campylobacter in children under the age of five years ranges from 2% in Sudan to 21% in South Africa. In poultry, the prevalence ranges from 14.4% in Ghana to 96% in Algeria. This review also highlights the alarming trend of increased Campylobacter resistance to clinically important antimicrobials, such as ciprofloxacin and erythromycin, in humans and food animals in Africa. This review adds to our understanding of the global epidemiology of Campylobacter at the human–food animal interface, with an emphasis from the African perspective. Interinstitutional and intersectoral collaborations, as well as the adoption of the One Health approach, would be useful in bridging the gaps in the epidemiological knowledge of Campylobacter in Africa.

show abstract

“…A total of 220,209 Campylobacter cases were reported and confirmed by the EU in humans in 2011, and 212,064 established cases in 2010 [5]. In developing countries, Campylobacter-related gastroenteritis rates are most common amongst children less than five years old [6].…”

Section: Introductionmentioning

confidence: 99%

Antibiotic resistance profiles of Campylobacter species in the South Africa private health care sector

Shobo

Bester

Baijnath

et al. 2016

J Infect Dev Ctries

View full text Add to dashboard Cite

Introduction: There is a dearth of surveillance data on clinical Campylobacter in South Africa, particularly in the private healthcare environment. We investigated the prevalence of resistance to first-line antibiotics used to treat campylobacterioses in clinical Campylobacter isolates from a private pathology laboratory. Methodology: Identification of the Campylobacter specific genes were confirmed by PCR. Minimum inhibitory concentrations were determined using the broth micro-dilution method against macrolides (erythromycin, azithromycin), fluoroquinolones (ciprofloxacin, gatifloxacin) and tetracycline. Results: Seventy-two Campylobacter isolates were identified by PCR, with 54 (75%) being classified as C. jejuni and 18 (25%) as C. coli. Of these, 11 (20.4%) C. jejuni and six (33.3%) C. coli strains were resistant to ciprofloxacin and three (7.41%) C. jejuni and three (16.7%) C. coli strains were resistant to gatifloxacin. The number of C. jejuni strains resistant to erythromycin and azithromycin was 17 (31.5%) and 36 (50%) respectively, while the resistance of C. coli strains to erythromycin and azithromycin were seven (38.9%) and 14 (77.8%) respectively. Resistance to tetracycline was detected in 10 (55.6%) C. coli and 14 (25.9%) C. jejuni strains. Conclusion: In the light of these resistant profiles, the lack of a South African Campylobacter surveillance program is of concern. Relatively high prevalence of resistance in clinical isolates of C. jejuni and C. coli to the fluoroquinolones, macrolides and tetracycline used in first line treatment is of great concern. The efficacy treating human campylobacteriosis should thus be revisited.

show abstract

<i>Campylobacter</i> Spp. Epidemiology and Antimicrobial Susceptibility in a Developing Country, Burkina Faso (West Africa)

Cited by 13 publications

References 30 publications

Prevalence, Risk Factors, and Antimicrobial Resistance Profiles of Thermophilic Campylobacter Species in Humans and Animals in Sub-Saharan Africa: A Systematic Review

Prevalence, Risk Factors, and Antimicrobial Resistance Profiles of Thermophilic Campylobacter Species in Humans and Animals in Sub-Saharan Africa: A Systematic Review

Campylobacter at the Human–Food Interface: The African Perspective

Antibiotic resistance profiles of Campylobacter species in the South Africa private health care sector

Contact Info

Product

Resources

About